The U.S. gene expression market was valued at USD 5,119 million in 2024 and is projected to reach USD 14,275 million by 2034, registering a CAGR of 10.8% from 2025 to 2034. The growing prevalence of chronic diseases and demand for personalized medicines have driven the market growth.
read more..